Aarhus University Hospital (AUH)
Aarhus University Hospital (AUH)
Partner Information uitklapper, klik om te openen
Aarhus University Hospital (AUH) is one of the largest hospitals in Denmark and situated in Aarhus, the second biggest city in Denmark. The hospital provides specialised treatment to citizens in the Central Denmark Region and other regions of Denmark. AUH employs 10,200 employees and has an availability of 1,150 beds. The hospital has 44 clinical departments. AUH has a major focus on research, development and delivery of highly specialised treatments and was appointed the best hospital in Denmark 12 years in a row and was in 2020 elected the 11th best hospital in the world (https://www.newsweek.com/best-hospitals-2020).
The departments involved in STOPSTORM are the Department of Cardiology and the Department of Oncology. The Department of Cardiology is an internationally renowned and highly specialised department for diagnosis and state-of-the-art treatment of every aspect of heart disease. The Electrophysiology (EP) section of the department performs approximately 1100 ablations and 1200 implantations of pacemakers and ICD’s per year. Each year we treat patients with VT by catheter ablation where energy delivery is insufficient to prevent recurrence of the arrhythmia. We have the skills and knowledge to perform state-of-the-art catheter ablation at our institution
The Department of Oncology offers basic and highly specialized cancer therapy to more than 12,000 patients annually. The department consists of a large outpatient department, 3 wards, a research department, and a radiotherapy section with 10 accelerators giving more than 55000 radiotherapy fractions per year. The radiotherapy section delivers SAbR treatment to over 250 cancer patients annually. Development of RT at AUH is supported by a large research group at both AUH and AU, including five full-time medical physics research professors. Ongoing relevant projects in the department include forefront work within dose response modelling, motion management and auto-segmentation
Personnel uitklapper, klik om te openen
Dr. Steen B. Kristiansen
Dr. Steen B. Kristiansen is senior consultant at Department of Cardiology, at AUH. Dr. Kristiansen will be the Coordinator of this project at AUH and he will be involved in patient selection and catheter ablations.
Dr. Marianne Marquard Knap
Dr. Marianne Marquard Knap is a senior consultant and radiation oncologist at AUH. She will be responsible for the patient treatment using her experience in thoracic radiotherapy treatment and research.
Dr. Azza Ahmed Khalil
Dr. Azza Ahmed Khalil is a senior consultants and radiation oncologist at AUH. She will be responsible for the patient treatment using her experience in thoracic radiotherapy treatment and research.
Ph.D Ditte Sloth Møller
Ph.D Ditte Sloth Møller is a senior medical physicists at AUH responsible for SBRT treatments. She has a long research track-record in image-guided and adaptive radiotherapy. She will be involved in the radiotherapy planning and treatment and the WP5 projects on cardiac auto-segmentation, motion management and dose-response modelling.
Ph.D Esben Schjødt Worm
Ph.D Esben Schjødt Worm is a senior medical physicists at AUH responsible for SBRT treatments.. He has a long research track-record in motion-management of SBRT treatments . He will be involved in the radiotherapy planning and treatment and the WP5 projects on cardiac auto-segmentation, motion management and dose-response modelling.
Ph.D Lone Hoffmann
Ph.D Lone Hoffmann is a senior medical physicists at AUH responsible for SBRT treatments. She has a long research track-record in dosimetry, image-guided radiotherapy and adaptive radiotherapy. She will be involved in the radiotherapy planning and treatment and the WP5 projects on cardiac auto-segmentation, motion management and dose-response modelling.
Publications uitklapper, klik om te openen
- Tofig B, Lukac P, Nielsen JM, et al. Radiofrequency ablation lesions in low-, intermediate- and normal-voltage myocardium: an in vivo study in a porcine heart model. Europace 2019; pii: euz247. doi: 10.1093/europace/euz247.
- Glashan CA, Tofig B, Tao Q, et al. Multisize electrodes for substrate identification in ischemic cardiomyopathy: validation by integration of whole heart histology. JACC Clin Electrophysio 2019; 5: 1130-40.
- Møller DS, Nielsen TB, Brink C, et al. Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study. Radiother Oncol. 2017; 124: 311-7.
- Møller DS, Holt MI, Alber M, et al. Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose. Radiother Oncol 2016; 121: 32-8.
- Worm ES, Hoyer M, Hansen R, et al. A prospective cohort study of gated stereotactic liver radiation therapy using continuous internal electromagnetic motion monitoring, Int J Radiat Oncol Biol Phys 2018; 101: 366-75.
